The Global Injection Grade Sodium Hyaluronate Market was valued at USD 239 Million in 2023 and is projected to reach USD 334.06 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period (2023-2030). This growth is being driven by increasing demand for minimally invasive cosmetic procedures, rising prevalence of musculoskeletal disorders, and expanding applications in ophthalmology and tissue engineering.

As the healthcare industry shifts toward innovative biopharmaceutical solutions, the spotlight is on the key manufacturers who are advancing medical-grade hyaluronic acid technologies. In this blog, we profile the Top 10 Companies in the Injection Grade Sodium Hyaluronate Industry—a mix of biotech innovators, pharmaceutical leaders, and specialty chemical producers shaping the future of medical applications.

🔟 1. Bloomage Biotechnology Corporation Limited

Headquarters: Jinan, China
Key Offering: Medical-grade Sodium Hyaluronate for dermal fillers, visco-supplementation

Bloomage is the world’s largest hyaluronic acid manufacturer, controlling approximately 40% of the global HA raw material market. Their injection-grade products meet USP, EP, and JP pharmacopoeia standards for medical applications.

Innovation Highlights:

• World’s first microbial fermentation HA production technology

• Pioneer in cross-linked HA gel technology

• Over 500 HA-related patents worldwide

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/285905/global-injection-grade-sodium-hyaluronate-forecast-market-2025-2032-260

9️⃣ 2. Lifecore Biomedical